Rationale: Glyphosate-surfactant herbicides (GlySH) are non-selective herbicides that are extensively used worldwide. A recent case report on GlySH poisoning suggested successful resuscitation upon using intravenous lipid emulsion (ILE) for refractory hypotension. The efficacy of ILE in GlySH poisoning remains unproven due to a lack of randomized controlled trials, and further evidence is required to clarify the mechanism by which ILE may reverse hypotension in GlySH poisoning.
Introduction
Glyphosate-surfactant herbicides (GlySH) are non-selective herbicides that are used worldwide. [1, 2] Although GlySH is generally considered to have low toxicity, [3] large amounts of ingestion may lead to life-threatening toxicity in humans. [4] [5] [6] In cases of severe GlySH intoxication, shock and arrhythmia may occur, which often do not respond well to fluid resuscitation or vasopressor administration. [7] Treatment for GlySH poisoning is primarily supportive in nature, with no effective antidotes specifically available against shock caused by GlySH. However, a recent case report suggested successful resuscitation using intravenous lipid emulsion (ILE) for refractory hypotension caused by GlySH poisoning. [8] In recent cases of a series of GlySH intoxications, ILE administration was associated with a lower incidence of hypotension and arrhythmia relative to the retrospective controls. [9] The efficacy of ILE in GlySH poisoning still remains unproven because of a lack of randomized controlled trials, and further evidence is required to clarify the mechanism by which ILE may reverse hypotension in GlySH poisoning. We, here, present a case report of documented hemodynamic changes in a patient with refractory hypotension caused by GlySH poisoning, after ILE administration. Informed written consent was obtained from the patient for publication of this case report.
Case report
A 46-year-old man presented to the emergency department 45 min following ingestion of approximately 200 cc of GlySH (41% glyphosate, polyoxyethyleneamine surfactant, water, and minor formulation ingredients). He had no history of any major illnesses. On arrival, he had a Glasgow Coma Scale (GCS) score of 13/15. His vital signs were as follows: blood pressure, 82/50 mmHg; pulse, 85 beats/min; respiratory rate, 25 breaths/min; and temperature, 36.2°C. His weight was 78 kg and physical examination revealed an injected throat and cold extremities with otherwise unremarkable findings. Drug screen was unremarkable, chest X-ray was normal, and an electrocardiogram showed no specific findings. Arterial blood gas analysis showed a pH of 7.28, PaO2 of 91.7 mmHg, PaCO2 of 32.3 mmHg, base deficit of À10.5 mmol/L, HCO3 of 14.9 mmol/L on room air. Serum lactic acid concentration was 3.3 mmol/L. There was no other significant abnormality in electrolytes or routine blood chemistry.
Fluid resuscitation was initiated. The patient remained hypotensive despite aggressive fluid resuscitation, and therefore, administration of norepinephrine was started intravenously at a rate of 0.25 mg/kg/min. The patient was started on continuous veno-venous hemodiafiltration (CVVHDF). At 3.5 h after poisoning, he became obtunded with a GCS score of 5/15. He was intubated and placed on mechanical ventilation. Noninvasive hemodynamic monitor (Vigileo TM monitor; Edward Lifesciences, USA) revealed a CO of 4.5 L/min and systemic vascular resistance (SVR) of 604 dynes·s·cm À5 with blood pressure of 63/35 mmHg (Table 1) . Because hypotension did not respond to fluid resuscitation and norepinephrine infusion, a bolus (100 mL) of ILE (SMOFlipid 20%; Fresenius Kabi, Germany) was infused with a subsequent 400 mL infusion over 4 h. A few minutes following the bolus of ILE, his blood pressure increased to 101/54 mmHg with CO of 6.5 L/min and SVR of 701 dynes·s·cm À5 . Blood pressure, CO, and stroke volume increased gradually over next 8.5 h. At 12 h after poisoning, his hemodynamic parameters were as follows: blood pressure, 148/71 mmHg; CO, 10.4 L/min, and SVR, 661 dynes·s·cm À5 . The clinical status gradually improved and norepinephrine could be tapered on hospital day (HD) 3. The patient was discharged at HD 10 without sequelae.
Discussion
Our case report describes quantitative hemodynamic changes following ILE in refractory shock caused by poisoning in humans. The key findings of our case are that ILE produced an increase in CO, but not in SVR. Fettiplace et al reported that lipid-emulsions exerted rapid, positive inotropic effects in both intact rat and isolated-heart models. [10] Although the definitive mechanism of action is yet to be determined, the likely explanation for improved hemodynamic performance is that plasma free fatty acids generated from infused lipid provide metabolic substrates for cardiac oxidative phosphorylation. [11] Stehr et al reported a significant increase in cardiac performance in a study of bupivacaine toxicity in isolated hearts of rats undergoing lipid perfusion at concentrations too low to support the lipid sink theory. [12] ILE administration did not cause an elevated heart rate, but increased the systolic blood pressure, which may support the role of ILE as an inotropic agent. [12] Our results suggest that ILE had direct inotropic effects. Heart rate and stroke volume both increased after ILE initiation, resulting in an increased CO. SVR showed a slight decrease in status and showed no significant changes after ILE initiation.
Another mechanistic possibility, although not mutually exclusive with direct inotropy, is the lipid sink theory. [13] Clinically important redistribution of glyphosate seems unlikely, given that it is a small, polar molecule with limited toxicity. The toxic effects observed following ingestion of GlySH formulations are generally attributed to the surfactant. [4] The surfactant component, however, has a lipophilic "tail," characteristic of detergent structures, which could plausibly associate with the circulating ILE particles. Studies using radio-or isotope-labeled glyphosate and surfactant, as reported by Weinberg et al, [14] are required to clarify whether ILE facilitates redistribution of GlySH components from cardiac myocytes. Clinicians considering ILE infusion should, however, be aware of the potential complications, [15] which are likely to make this modality inappropriate for patients with less than serious-to-life-threatening toxicity.
Conclusion
If shock caused by GlySH poisoning responds poorly to conventional fluid and vasopressor therapy, ILE could be tried as a potential rescue treatment. The underlying mechanism of rescue with ILE may be a positive inotropic effect, although redistributive phenomenon cannot be presently ruled out. We hypothesize that ILE may have a role in treating refractory hypotension caused by GlySH poisoning. Further reports, as well as animal and clinical studies, are required to verify this conclusion. 
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